Showing results (551-560 of 1,179) with videos related to
Sort By:
Pageof 118
BMJ Open|June 27, 2025
Outcomes of patient and public involvement in the development of the Cognitive Decline after Brain Radiosurgery (CoDe B-Rad) study: refining the research question and methodologyAnna Bangiri, Adele Horobin, Julia Baker, et al.Cellular & Molecular Immunology|August 30, 2022
Treatment with a JAK1/2 inhibitor ameliorates murine autoimmune cholangitis induced by IFN overexpressionTihong Shao, Patrick S C Leung, Weici Zhang, et al.Journal of Autoimmunity|October 23, 2013
Recombinant soluble CD137 prevents type one diabetes in nonobese diabetic miceKritika Kachapati, Kyle J Bednar, David E Adams, et al.Hepatology (Baltimore, Md.)|December 10, 2008
Differential mechanisms in the pathogenesis of autoimmune cholangitis versus inflammatory bowel disease in interleukin-2Ralpha(-/-) miceWilly Hsu, Weici Zhang, Koichi Tsuneyama, et al.IEEE Transactions on Medical Imaging|December 28, 2019
Model-Based Iterative Reconstruction for Propagation-Based Phase-Contrast X-Ray CT including Models for the Source and the DetectorLorenz Hehn, Regine Gradl, Martin Dierolf, et al.European Journal of Public Health|February 7, 2019
Mid-life social participation and physical performance at age 60-64: evidence from the 1946 British Birth Cohort StudyA Vusirikala, Y Ben-Shlomo, D Kuh, et al.Inorganic Chemistry|July 14, 2021
Heisenberg Spin Chains via Chalcogen Bonding: Noncovalent S···O Contacts Enable Long-Range Magnetic OrderR Alex Mayo, Ian S Morgan, Dmitriy V Soldatov, et al.Occupational and Environmental Medicine|February 5, 2000
Reproductive endocrine effects of acute exposure to toluene in men and womenU Luderer, M S Morgan, C A Brodkin, et al.Risk Analysis : an Official Publication of the Society for Risk Analysis|April 15, 2000
Individual prior information in a physiological model of 2H8-toluene kinetics: an empirical Bayes estimation strategyP Vicini, C H Pierce, R L Dills, et al.Leukemia & Lymphoma|January 21, 2012
Toxicities and outcomes among septuagenarians and octogenarians with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone therapyScott F Huntington, Mahsa S Talbott, John P Greer, et al.Pageof 118